SLR Capital Partners

SLR Capital Partners specializes in direct lending and asset-based financing for U.S. middle market companies across diverse sectors including healthcare and life sciences. Its Life Science Finance team provides senior secured loans to later-stage drug, device, diagnostic, healthcare IT and services companies—typically those with strong institutional backing and late clinical or early commercial stage assets.

The firm manages public/private investment vehicles including the publicly traded BDC SLR Investment Corp. (NASDAQ SLRC), with over $16 billion invested since inception across more than 1,500 portfolio companies. In life sciences specifically, the team has originated over $1.7 billion in more than 76 transactions since joining the platform.

As an asset manager/lender rather than an operator of clinical programs or products itself, it does not have its own pipeline of therapeutics.